| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Shukla Sanjay is a President And CEO at aTYR PHARMA INC. Recent SEC Form 4 filings include 1 buy and 1 sell.
Estimated insider holdings value: $137K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | ATYR Atyr Pharma Inc | President And CEO | Buy | 6,000 | $4.27 | $25,620.00 | +464.8% | |
| Feb 7, 2020 | ATYR Atyr Pharma Inc | President And CEO | Sale+OE | 745 | $4.03 | $3,002.35 | -36.6% |